Hey there, this is Ari and welcome back to the Energy Blueprint podcast.

Today I have a very interesting guest for you.

His name is Mark Effinger, otherwise known as Mr. Newatropics. And he is the chief product officer and formulator

of a line of newotropic supplements from a company called Neuatopia. And this is a line of products

I've known about now for about a year. I have not tried any of these products yet.

They are, as I'm publishing this podcast, they are sending me some to try out, and I will

certainly update with my thoughts on them. As far as the formulations themselves, they look very

interesting. However, many of the compounds in them are trademarked and it's hard to know what's actually

in the formulas and therefore it's very hard to evaluate them from the perspective of the

body of established scientific literature, peer-reviewed, journal published data on different

compounds and their effects,

which is, generally speaking, where we draw conclusions from or where we can infer opinions

about certain formulations. Like, I can look at any formulation on Amazon and say, oh, you know,

it's only got one-tenth the proper dosage of this compound,

or it doesn't have this key compound, it doesn't have that key compound, or it's, it's underdosed

by a factor of, you know, one-120th of the proper amounts of all these different compounds.

Or, you know, it's just a silly little formula that they're you know very commonly you see things

that are like you know if they throw some B vitamins in there some vitamin C and then a couple

you know herbs of various kinds that are you know not anywhere close to the the effective dosage

what newotopia is doing is is different, which is potentially very good, but the other

side of it is that it makes it pretty much impossible for me to actually objectively evaluate

what they're doing from the perspective of the established science. Now, their body of knowledge of data

...